Form 4: CareDx Director Peter Maag Reports Acquisition of Common Stock

Director Peter Maag acquired 1,034 shares of CareDx, Inc. common stock on July 8, 2024, through an automatic quarterly grant in lieu of cash compensation.

Summary

• Peter Maag, a director of CareDx, Inc., reported a transaction involving the company's common stock.
• On July 8, 2024, Maag acquired 1,034 shares of common stock.
• The acquisition was an automatic quarterly grant in lieu of cash for non-employee director compensation.
• The price per share was $0.00.
• Following the transaction, Maag directly owns 338,868 shares of CareDx, Inc. common stock.

Sentiment

Score: 7

Explanation: Director acquiring shares is generally a positive sign, indicating confidence in the company's prospects. The grant is part of a pre-existing compensation plan, so it's not a surprise, but still a positive indicator.

Positives

• The acquisition of shares by a director signals confidence in the company.

Industry Context

Director share acquisitions are common and are viewed as a positive sign of confidence in the company's future.

Comparison to Industry Standards

• Director compensation packages often include stock grants to align their interests with shareholders.
• The frequency and size of these grants vary depending on the company's size, industry, and compensation policies.
• Comparing CareDx's director compensation policy with those of similar companies in the biotechnology sector would provide further context.

Related Party Transactions

• The stock grant to Peter Maag is a related party transaction as he is a director of CareDx, Inc.

Stakeholder Impact

• The acquisition of shares by a director can positively influence shareholder sentiment.

Key Dates